Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association
As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …
Is HIV a model of accelerated or accentuated aging?
Background. Antiretroviral therapy has reduced the incidence of adverse events and early
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
mortality in HIV-infected persons. Despite these benefits, important comorbidities that …
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
B Julg, L Dee, J Ananworanich, DH Barouch, K Bar… - The lancet HIV, 2019 - thelancet.com
Analytical antiretroviral treatment interruption (ATI) is an important feature of HIV research,
seeking to achieve sustained viral suppression in the absence of antiretroviral therapy (ART) …
seeking to achieve sustained viral suppression in the absence of antiretroviral therapy (ART) …
Inflammation, immune activation, and cardiovascular disease in HIV
E Nou, J Lo, SK Grinspoon - Aids, 2016 - journals.lww.com
Cardiovascular disease is one of the leading causes of morbidity and mortality in people
living with HIV. Several epidemiological studies have shown an increased risk of myocardial …
living with HIV. Several epidemiological studies have shown an increased risk of myocardial …
HIV-1–associated atherosclerosis: unraveling the missing link
Cardiovascular disease, including atherosclerosis and atherosclerosis-associated
complications, is an increasing cause of morbidity and mortality in human immunodeficiency …
complications, is an increasing cause of morbidity and mortality in human immunodeficiency …
HIV post-treatment controllers have distinct immunological and virological features
HIV post-treatment controllers (PTCs) are rare individuals who maintain low levels of viremia
after stopping antiretroviral therapy (ART). Understanding the mechanisms of HIV post …
after stopping antiretroviral therapy (ART). Understanding the mechanisms of HIV post …
Cardiovascular disease and HIV infection
VA Triant - Current HIV/AIDS Reports, 2013 - Springer
The emergence of chronic disease complications in controlled HIV disease has changed the
landscape of HIV clinical care. HIV infection confers an increased cardiovascular disease …
landscape of HIV clinical care. HIV infection confers an increased cardiovascular disease …
Unravelling the mechanisms of durable control of HIV-1
Untreated HIV-1 infection typically progresses to AIDS within 10 years, but less than 1% of
infected individuals remain healthy and have normal CD4+ T cell counts and undetectable …
infected individuals remain healthy and have normal CD4+ T cell counts and undetectable …
Aging with HIV
G Guaraldi, J Milic, C Mussini - Current HIV/AIDS Reports, 2019 - Springer
Abstract Purpose of Review This review points out unmet medical needs and open research
questions of older adults living with HIV. Starting from the definition of aging in HIV, it …
questions of older adults living with HIV. Starting from the definition of aging in HIV, it …
Monocyte/macrophages and their role in HIV neuropathogenesis
Neurological sequelae of human immunodeficiency virus (HIV) infection have been and
remain a significant problem. Monocytes and macrophages in humans and monkeys are …
remain a significant problem. Monocytes and macrophages in humans and monkeys are …